173 related articles for article (PubMed ID: 9227869)
1. Incidental appendix carcinoid. Value of somatostatin receptor imaging.
Hoegerle S; Nitzsche EU; Stumpf A; Simon GH; Otte A; Schwarzkopf G; Moser E
Clin Nucl Med; 1997 Jul; 22(7):467-9. PubMed ID: 9227869
[TBL] [Abstract][Full Text] [Related]
2. [Isotopic scan with somatostatin receptors in a case of recurrent carcinoid tumor. Relevance of tomographic detection].
Bernà Roqueta L; Martín Marimón JC; Martín Martínez J
Rev Esp Med Nucl; 2002 Apr; 21(2):123-4. PubMed ID: 11879622
[No Abstract] [Full Text] [Related]
3. [The scintigraphy of somatostatin receptors in the carcinoid tumor].
Banzo J; Abós MD; Prats E; Delgado M; Razola P; García S; Gomollón F; García F
Rev Esp Med Nucl; 2001 Feb; 20(1):11-8. PubMed ID: 11181324
[TBL] [Abstract][Full Text] [Related]
4. Somatostatin receptor scintigraphy of carcinoid tumours using the [111In-DTPA-D-Phe1]-octreotide.
Westlin JE; Janson ET; Arnberg H; Ahlström H; Oberg K; Nilsson S
Acta Oncol; 1993; 32(7-8):783-6. PubMed ID: 8305227
[TBL] [Abstract][Full Text] [Related]
5. In-111 DTPA octreotide scintigraphy and intraoperative gamma probe detection in the diagnosis and treatment of residual lymph node metastases of a rectal carcinoid tumor.
Banzo J; Vidal-Sicat S; Prats E; Galofré G; Razola P; Mañé S; Ubieto MA; Abós MD
Clin Nucl Med; 2005 May; 30(5):308-11. PubMed ID: 15827397
[TBL] [Abstract][Full Text] [Related]
6. Vasoactive intestinal peptide and somatostatin receptor scintigraphy for differential diagnosis of hepatic carcinoid metastasis.
Kurtaran A; Raderer M; Müller C; Prokesch R; Kaserer K; Eibenberger K; Koperna K; Niederle B; Virgolini I
J Nucl Med; 1997 Jun; 38(6):880-1. PubMed ID: 9189133
[TBL] [Abstract][Full Text] [Related]
7. [Somatostatin receptor scintigraphy in pediatric bronchial carcinoid tumor].
Hervás Benito I; Bello Arques P; Loaiza JL; Vercher JL; Velasco RP; Rivas Sánchez A; Ruiz Llorca C; Martí Vidal JF; Mateo Navarro A
Rev Esp Med Nucl; 2010; 29(1):25-8. PubMed ID: 19819594
[TBL] [Abstract][Full Text] [Related]
8. [Bronchial carcinoid tumor and scintigraphy of somatostatin receptors: detection of bone metastasis].
Banzo J; Abós MD; Prats E; García F; Freile E; Razola P; Escalera T
Rev Esp Med Nucl; 2001 Oct; 20(6):431-8. PubMed ID: 11578577
[TBL] [Abstract][Full Text] [Related]
9. Gastroenteropancreatic tumor imaging with somatostatin receptor scintigraphy.
Wiedenmann B; Bäder HM; Scherubl H; Fett U; Zimmer T; Hamm B; Koppenhagen K; Riecken EO
Semin Oncol; 1994 Oct; 21(5 Suppl 13):29-32. PubMed ID: 7992077
[No Abstract] [Full Text] [Related]
10. Metastatic carcinoid tumor imaged with CT and a radiolabeled somatostatin analog: a case report.
Lobrano MB; McCarthy K; Adams L; Neitzschman H
Am J Gastroenterol; 1997 Mar; 92(3):513-5. PubMed ID: 9068482
[TBL] [Abstract][Full Text] [Related]
11. Receptor scintigraphy with 111In-pentetreotide for endocrine gastroenteropancreatic tumors.
Joseph K; Stapp J; Reinecke J; Skamel HJ; Höffken H; Neuhaus C; Lenze H; Trautmann ME; Arnold R
Horm Metab Res Suppl; 1993; 27():28-35. PubMed ID: 8330869
[TBL] [Abstract][Full Text] [Related]
12. Use of somatostatin receptor scintigraphy to image extrahepatic metastases of neuroendocrine tumors.
Frilling A; Malago M; Martin H; Broelsch CE
Surgery; 1998 Dec; 124(6):1000-4. PubMed ID: 9854575
[TBL] [Abstract][Full Text] [Related]
13. [Carcinoid of the appendix. A case report].
Spallitta SI; Termine G; Stella M; Calistro V; Marozzi P
Minerva Chir; 2000; 55(1-2):77-87. PubMed ID: 10832290
[TBL] [Abstract][Full Text] [Related]
14. Nuclear localization of 111In after intravenous injection of [111In-DTPA-D-Phe1]-octreotide in patients with neuroendocrine tumors.
Janson ET; Westlin JE; Ohrvall U; Oberg K; Lukinius A
J Nucl Med; 2000 Sep; 41(9):1514-8. PubMed ID: 10994731
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness analysis of somatostatin receptor scintigraphy.
Kwekkeboom DJ; Lamberts SW; Habbema JD; Krenning EP
J Nucl Med; 1996 Jun; 37(6):886-92. PubMed ID: 8683305
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis of ectopic ACTH production from a bronchial carcinoid by imaging with octreotide scintigraphy.
Kristoffersson A; Olsson T; Björnebrink J; Hägg E
Eur J Surg; 1996 Jun; 162(6):515-8. PubMed ID: 8817232
[No Abstract] [Full Text] [Related]
17. Use of an isotopic somatostatin receptor probe to image gut endocrine tumors.
Modlin IM; Cornelius E; Lawton GP
Arch Surg; 1995 Apr; 130(4):367-73; discussion 373-4. PubMed ID: 7710334
[TBL] [Abstract][Full Text] [Related]
18. Somatostatin receptor scintigraphy in patients with carcinoid tumors: comparison between radioligand uptake and tumor markers.
Kälkner KM; Janson ET; Nilsson S; Carlsson S; Oberg K; Westlin JE
Cancer Res; 1995 Dec; 55(23 Suppl):5801s-5804s. PubMed ID: 7493349
[TBL] [Abstract][Full Text] [Related]
19. Intraoperative detection of somatostatin-receptor-positive neuroendocrine tumours using indium-111-labelled DTPA-D-Phe1-octreotide.
Wangberg B; Forssell-Aronsson E; Tisell LE; Nilsson O; Fjalling M; Ahlman H
Br J Cancer; 1996 Mar; 73(6):770-5. PubMed ID: 8611378
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic reliability of somatostatin receptor scintigraphy during continuous treatment with different somatostatin analogs.
Dörr U; Wurm K; Höring E; Guzman G; Räth U; Bihl H
Horm Metab Res Suppl; 1993; 27():36-43. PubMed ID: 8330870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]